Kennedy Capital Management’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RA
RHJA
PHP
BAM
Kennedy Capital Management's OPRX Position: Q2 2026 in Review
Kennedy Capital Management reduced its OptimizeRx (OPRX) stake by 1.8% in Q2 2026, selling an estimated $69.6K and leaving 644,150 shares worth $3.68M. The position accounts for 0.07% of the portfolio, ranked #369.
Kennedy Capital Management first reported a position in OPRX in Q1 2020 and has held it in 16 quarters since. The position peaked at $13.8M in Q3 2025. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.
- Kennedy Capital Management held 644,150 shares of OptimizeRx worth $3.68M as of Q2 2026.
- Kennedy Capital Management sold 12,108 OptimizeRx shares in Q2 2026, an estimated $69.6K.
- OptimizeRx made up 0.07% of Kennedy Capital Management's portfolio in Q2 2026, its #369 holding.
- Kennedy Capital Management first reported a position in OptimizeRx in Q1 2020 and has held it in 16 quarters since.
- Kennedy Capital Management's OptimizeRx position peaked at $13.8M in Q3 2025.
- 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.
Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.